HORIBA, Ltd.
Stock Price Chart
2026/01/16 UpdatedPrice Trend
2026/01/16 UpdatedPrice & Trading Details
2026/01/16 UpdatedPRICE
TRADING
Analyst Recommendations 6 analysts
Updated 2026/01/11Shareholder Composition
Updated 2026/01/11Top Mutual Funds / ETFs
Updated 2026/01/11Major Holders
Updated 2026/01/11| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
550.9K | +0.44% | |
|
T. ROWE PRICE Intl Fd.S, INC.-T. Rowe Price Intl Discovery Fd.
|
460.0K | -0.24% | |
|
HARTFORD MUTUAL FUNDS INC/CT-The Hartford International Value Fund
|
457.8K | +10.54% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
351.9K | +3.53% | |
|
Third Avenue Trust-THIRD AVENUE VALUE FUND
|
336.1K | 0.00% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
227.3K | +2.53% |
| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Fifth Lane Capital, LP
|
1.8K | +1.00% |
Dividend History 1Years Growth
Updated 2026/01/11| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥290 | +7.4% |
| 2024 | ¥270 | -6.9% |
| 2023 | ¥290 | +18.4% |
| 2022 | ¥245 | +63.3% |
| 2021 | ¥150 | - |
Financial Performance
2026/01/11 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥224,314M | ¥270,133M | ¥290,558M | ¥317,369M |
| Gross Profit | ¥93,222M | ¥116,674M | ¥127,383M | ¥136,854M |
| Operating Income | ¥32,047M | ¥45,844M | ¥47,297M | ¥48,340M |
| Pretax Income | ¥30,720M | ¥47,929M | ¥54,425M | ¥49,756M |
| Net Income | ¥21,311M | ¥34,072M | ¥40,302M | ¥33,591M |
| EPS | ¥502.46 | ¥802.89 | ¥948.83 | ¥795.34 |
| Operating Margin | 14.29% | 16.97% | 16.28% | 15.23% |
| Balance Sheet | ||||
| Total Assets | ¥371,585M | ¥416,742M | ¥449,030M | ¥481,616M |
| Total Equity | ¥204,479M | ¥240,833M | ¥283,713M | ¥314,688M |
| Total Liabilities | ¥167,106M | ¥175,909M | ¥165,317M | ¥166,928M |
| Cash | ¥135,023M | ¥139,855M | ¥132,775M | ¥144,272M |
| Interest-bearing Debt | ¥80,184M | ¥67,205M | ¥60,394M | ¥64,404M |
| Equity Ratio | 55.03% | 57.79% | 63.18% | 65.34% |
| D/E Ratio | 0.39 | 0.28 | 0.21 | 0.20 |
| Cash Flow | ||||
| Operating CF | ¥35,268M | ¥33,966M | ¥16,652M | ¥40,335M |
| Investing CF | -¥14,662M | -¥10,745M | -¥7,315M | -¥17,562M |
| Financing CF | -¥4,045M | -¥22,447M | -¥20,963M | -¥15,933M |
| Free CF | ¥22,696M | ¥21,883M | ¥7,481M | ¥20,888M |
| Efficiency | ||||
| ROE | 10.42% | 14.15% | 14.21% | 10.67% |
| ROA | 5.74% | 8.18% | 8.98% | 6.97% |
Latest IR Information
-
No IR information found for this company.
Searched stock code: 6856
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥16,250
Rating Score: - (Based on 6 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
HORIBA, Ltd., together with its subsidiaries, provides analytical and measurement solutions in Japan and internationally. It operates in three segments: Energy and Environment; Bio and Healthcare; and Materials and Semiconductor. The company offers mobility products, including systems for emissions measurement, internal combustion engine and brake testing, driveline and powertrain evaluation, and wind tunnel; and energy and environment solutions for water and liquid, industrial process, and energy, such hydrogen energy, carbon capture and utilization, battery manufacturing/recycling, energy usage optimization, ammonia co-firing, and oil refinery, as well as thermal, waste to energy, and biogas/biomass generation. It also provides life science products comprising fluorescence spectroscopy, raman imaging and spectrometers, and particle characterization; healthcare solutions, which include vitro diagnostic systems for biological analysis, clinical chemistry, veterinary, hematology, and hemostasis; material analysis, such as elemental analysis, molecular and structural analysis, and surface analysis and thin film characterization; and semiconductor products. In addition, the company offers technology solutions comprising particle analysis, fluid control, mass spectrometry, microscopy and imaging, physisorption, spectroscopy, and surface plasmon resonance; and services, including analysis centers, calibration and certification, customer support, spare parts and consumables, testing and consulting, and product and technology training. Its products are used in arts, entertainment, and recreation; biopharma and pharma, biotechnology and biomedical; cosmetics; education, research and development, and government institution; energy solutions; food and beverage; healthcare; industrials; information technology; materials; mobility and transportation; waste management; and water applications. The company was founded in 1945 and is headquartered in Kyoto, Japan.